Impact of repeated co-treatment with escitalopram and aripiprazole on the schizophrenia-like behaviors and BDNF mRNA expression in the adult Sprague–Dawley rats exposed to glutathione deficit during early postnatal development of the brain

Glutathione Deficiency during Early Postnatal Development Causes Schizophrenia-Like Symptoms and a Reduction in BDNF Levels in the Cortex and Hippocampus of Adult Sprague–Dawley Rats

(2021) Marta Anna Lech et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Potential Roles of Redox Dysregulation in the Development of Schizophrenia

(2020) Diana O. Perkins et al.   BIOLOGICAL PSYCHIATRY

Alterations in the Antioxidant Enzyme Activities in the Neurodevelopmental Rat Model of Schizophrenia Induced by Glutathione Deficiency during Early Postnatal Life

(2020) Magdalena Górny et al.   Antioxidants

Co-treatment with antidepressants and aripiprazole reversed the MK-801-induced some negative symptoms of schizophrenia in rats

(2019) Marta Hereta et al.   Pharmacological Reports

Glutathione Deficiency and Alterations in the Sulfur Amino Acid Homeostasis during Early Postnatal Development as Potential Triggering Factors for Schizophrenia-Like Behavior in Adult Rats

(2019) Magdalena Górny et al.   MOLECULES

Repeated co-treatment with antidepressants and risperidone increases BDNF mRNA and protein levels in rats

(2017) Zofia Rogóż et al.   Pharmacological Reports

Redox dysregulation, neuroinflammation, and NMDA receptor hypofunction: A “central hub” in schizophrenia pathophysiology?

(2016) P. Steullet et al.   SCHIZOPHRENIA RESEARCH

The effect of combined treatment with risperidone and antidepressants on the MK-801-induced deficits in the social interaction test in rats

(2015) Katarzyna Kamińska et al.   Pharmacological Reports

The Novel Object Recognition Test in Rodents in Relation to Cognitive Impairment in Schizophrenia

(2014) Lakshmi Rajagopal et al.   CURRENT PHARMACEUTICAL DESIGN

Repeated aripiprazole treatment regulates Bdnf, Arc and Npas4 expression under basal condition as well as after an acute swim stress in the rat brain

(2013) Alessia Luoni et al.   PHARMACOLOGICAL RESEARCH

Decreased glutathione levels and impaired antioxidant enzyme activities in drug-naive first-episode schizophrenic patients

(2011) Monia Raffa et al.   BMC Psychiatry

Time-dependent effects of escitalopram on brain derived neurotrophic factor (BDNF) and neuroplasticity related targets in the central nervous system of rats

(2010) Silvia Alboni et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Childhood onset schizophrenia: support for a progressive neurodevelopmental disorder

(2010) Judith L. Rapoport et al.   INTERNATIONAL JOURNAL OF DEVELOPMENTAL NEUROSCIENCE

Decreased levels of glutathione, the major brain antioxidant, in post-mortem prefrontal cortex from patients with psychiatric disorders

(2010) Jeremy W. Gawryluk et al.   INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY

Oxidative stress in schizophrenia: An integrated approach

(2010) Byron K.Y. Bitanihirwe et al.   NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS

Animal models of cognitive dysfunction and negative symptoms of schizophrenia: Focus on NMDA receptor antagonism

(2010) Joanna C. Neill et al.   PHARMACOLOGY & THERAPEUTICS

Mirtazapine augmentation enhances cognitive and reduces negative symptoms in schizophrenia patients treated with risperidone: A randomized controlled trial

(2010) Sung Joon Cho et al.   PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY

Redox dysregulation, neurodevelopment, and schizophrenia

(2009) Kim Q Do et al.   CURRENT OPINION IN NEUROBIOLOGY

Decreased glutathione levels and antioxidant enzyme activities in untreated and treated schizophrenic patients

(2009) Monia Raffa et al.   PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY

The effect of mirtazapine add on therapy to risperidone in the treatment of schizophrenia: A double-blind randomized placebo-controlled trial

(2009) Seyed-Hesameddin Abbasi et al.   SCHIZOPHRENIA RESEARCH

Differential effects of ziprasidone and haloperidol on immobilization stress-induced mRNA BDNF expression in the hippocampus and neocortex of rats

(2008) Sung Woo Park et al.   JOURNAL OF PSYCHIATRIC RESEARCH

The pharmacokinetics of standard antidepressants with aripiprazole as adjunctive therapy: studies in healthy subjects and in patients with major depressive disorder

(2008) DW Boulton et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Gene-Environment Interactions in Schizophrenia: Review of Epidemiological Findings and Future Directions

(2008) J. van Os et al.   SCHIZOPHRENIA BULLETIN